TaiwanBiotech Take-Off Plan and new rules
This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight
Taiwan’s Executive Yuan announced its Biotech Take- Off Diamond Plan in 2009. The strategic plan is designed to strengthen trust in the infrastructure of IP protection through world-class expertise in integrating electronics and semiconductors, and to transform Taiwan into a regional hub for biotech research and development (R&D), manufacturing and operations. This strategic plan aims to provide an efficient mechanism to ease the transition between research and pre-clinical development for new drugs and medical devices. Under the plan, a biotech venture capital fund of $1.76 billion, the so-called ‘mega fund’, has been established for start-ups. In addition, several changes have been made to IP regulations and infrastructures in Taiwan in order to ensure good IP practice in Taiwan, especially in the field of biotechnology.
Download